Zobrazeno 1 - 10
of 253
pro vyhledávání: '"satralizumab"'
Autor:
Chuanbin Sun, Zhe Liu
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
The treatment of demyelinating optic neuritis (DON) in pregnant patients is challenging, especially when there is poor or no response to intravenous methylprednisolone pulse (IVMP) therapy or adjunctive treatments such as intravenous immunoglobulin (
Externí odkaz:
https://doaj.org/article/36f163ad9ca248a38b1d43a54d41939b
Autor:
Chuanbin Sun
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Demyelinating optic neuritis (DON) is a rare but sight-threatening ophthalmic condition which occasionally occurs after human papilloma virus (HPV) vaccination. We herein report a case of previously healthy 13-year-old girl who developed a bilateral
Externí odkaz:
https://doaj.org/article/f5260f5e8a794f9aa54d7bb97f377e49
Autor:
Soon-Tae Lee, Hesham Abboud, Sarosh R. Irani, Hideto Nakajima, Amanda L. Piquet, Sean J. Pittock, E. Ann Yeh, Jiawei Wang, Sharmila Rajan, James Overell, Jillian Smith, Jane St Lambert, Muna El-Khairi, Marina Gafarova, Jeffrey M. Gelfand
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
BackgroundAutoimmune encephalitis (AIE) encompasses a spectrum of rare autoimmune-mediated neurological disorders, which are characterized by brain inflammation and dysfunction. Autoantibodies targeting the N-methyl-d-aspartic acid receptor (NMDAR) a
Externí odkaz:
https://doaj.org/article/8e934d562b244ba88ff1f00093c8fd1c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
P. A. Zaitseva, A. N. Boyko
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 15, Iss 0, Pp 49-57 (2023)
In the review, we present the main pathogenetic mechanisms of the development of neuromyelitis optic spectrum disorders (NMOSD) associated with the appearance of anti-aquaporin-4 (APQ4-IgG) autoantibodies: damage to astrocytes, including complement-d
Externí odkaz:
https://doaj.org/article/29075cb166714f579a4fc27c42fe3578
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Takashi Yoshida, Osamu Watanabe, Miwa Nomura, Yusuke Yoshimoto, Yoshimitsu Maki, Hiroshi Takashima
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
BackgroundSatralizumab, a monoclonal antibody that recognizes interleukin-6 receptors, is known to reduce the relapse rate in neuromyelitis optica spectrum disorder (NMOSD), but its safety during pregnancy has not been established. We present the cas
Externí odkaz:
https://doaj.org/article/a3f9a66e400549cd8829e7e897031cd2
Autor:
Xiaojing Li, Wenlin Wu, Yiru Zeng, Wenxiao Wu, Chi Hou, Haixia Zhu, Yinting Liao, Yang Tian, Zongzong Chen, Bingwei Peng, Wen-Xiong Chen
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disease of the central nervous system. Relapse and incomplete recovery from relapse are common in NMOSD. Most patients with NMOSD have IgG to aquaporin-4 (AQP4-IgG). New biological a
Externí odkaz:
https://doaj.org/article/83033c8d0436439984a7758a7b163793
Publikováno v:
Frontiers in Ophthalmology, Vol 3 (2023)
Neuromyelitis Optica spectrum disorder (NMOSD) is a relapsing autoimmune disease of the central nervous system (CNS) where aquaporin-4 water channels are the antigenic target of the disease. The spectrum of the disease involves regions of the CNS whe
Externí odkaz:
https://doaj.org/article/e8bb412f01c748929f99e420c515dda6
Autor:
Jeffrey L. Bennett, Kazuo Fujihara, Ho Jin Kim, Romain Marignier, Kevin C. O'Connor, Robert C. Sergott, Anthony Traboulsee, Heinz Wiendl, Jens Wuerfel, Scott S. Zamvil, Veronica G. Anania, Regine Buffels, Thomas Künzel, Annemarie N. Lekkerkerker, Siân Lennon-Chrimes, Sean J. Pittock
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
BackgroundNeuromyelitis optica spectrum disorder (NMOSD) is a rare, autoimmune disease of the central nervous system that produces acute, unpredictable relapses causing cumulative neurological disability. Satralizumab, a humanized, monoclonal recycli
Externí odkaz:
https://doaj.org/article/65073f7848d74c30812b90f40057ec13